Randomized Clinical Trial of the Innovative Bilayered Wound Dressing Made of Silk and Gelatin: Safety and Efficacy Tests Using a Split-Thickness Skin Graft Model

Hasatsri, Sukhontha; Angspatt, Apichai; Aramwit, Pornanong

doi:10.1155/2015/206871

Cited by 31 publications

(35 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similarly, lyophilized bovine amniotic membrane has been effective in wound healing applications (Kang et al, 2013). The silk protein, fibroin, is an effective scaffolding material providing a fine mesh for the cells to grow and enhance wound healing (Hasatsri et al, 2015). A phase I clinical trial using fibroin to enhance wound healing is currently underway.…”

Section: Biomaterial-based Wound Therapiesmentioning

confidence: 99%

Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing

Baker

2016

Front. Bioeng. Biotechnol.

254

196

View full text Add to dashboard Cite

Wound healing is an intricate process that requires complex coordination between many cell types and an appropriate extracellular microenvironment. Chronic wounds often suffer from high protease activity, persistent infection, excess inflammation, and hypoxia. While there has been intense investigation to find new methods to improve cutaneous wound care, the management of chronic wounds, burns, and skin wound infection remain challenging clinical problems. Ideally, advanced wound dressings can provide enhanced healing and bridge the gaps in the healing processes that prevent chronic wounds from healing. These technologies have great potential for improving outcomes in patients with poorly healing wounds but face significant barriers in addressing the heterogeneity and clinical complexity of chronic or severe wounds. Active wound dressings aim to enhance the natural healing process and work to counter many aspects that plague poorly healing wounds, including excessive inflammation, ischemia, scarring, and wound infection. This review paper discusses recent advances in the development of biomaterials and nanoparticle therapeutics to enhance wound healing. In particular, this review focuses on the novel cutaneous wound treatments that have undergone significant preclinical development or are currently used in clinical practice.

show abstract

Section: Biomaterial-based Wound Therapiesmentioning

confidence: 99%

Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing

Baker

2016

Front. Bioeng. Biotechnol.

254

196

View full text Add to dashboard Cite

show abstract

“…Increased utilization of validated pain and scar scales are seen. 19 , 22 , 23 , 36 – 53 Vast differences among the included dressings weaken this review. Well-established dressings are being compared with novel dressings being studied for the first time without standardized means for comparison.…”

Section: Discussionmentioning

confidence: 99%

Meta-analysis and Systematic Review of Skin Graft Donor-site Dressings with Future Guidelines

Serebrakian

Pickrell

Varon

et al. 2018

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

Background:Many types of split-thickness skin graft (STSG) donor-site dressings are available with little consensus from the literature on the optimal dressing type. The purpose of this systematic review was to analyze the most recent outcomes regarding moist and nonmoist dressings for STSG donor sites.Methods:A comprehensive systematic review was conducted across PubMed/MEDLINE, EMBASE, and Cochrane Library databases to search for comparative studies evaluating different STSG donor-site dressings in adult subjects published between 2008 and 2017. The quality of randomized controlled trials was assessed using the Jadad scale. Data were collected on donor-site pain, rate of epithelialization, infection rate, cosmetic appearance, and cost. Meta-analysis was performed for reported pain scores.Results:A total of 41 articles were included comparing 44 dressings. Selected studies included analysis of donor-site pain (36 of 41 articles), rate of epithelialization (38 of 41), infection rate (25 of 41), cosmetic appearance (20 of 41), and cost (10 of 41). Meta-analysis revealed moist dressings result in lower pain (pooled effect size = 1.44). A majority of articles (73%) reported better reepithelialization rates with moist dressings.Conclusion:The literature on STSG donor-site dressings has not yet identified an ideal dressing. Although moist dressings provide superior outcomes with regard to pain control and wound healing, there continues to be a lack of standardization. The increasing commercial availability and marketing of novel dressings necessitates the development of standardized research protocols to design better comparison studies and assess true efficacy.

show abstract

“…Therefore, the process of selecting the optimal dressing should include the following parameters: the price, availability, effectiveness, and safety. Other important complementary treatments include physiotherapy, genetic counselling, aggressive treatment of infections, nutritional supplementation, and skin cancer monitoring [17][18][19][20][21][22][23][24][25][26][27][28][29][30][31].…”

Section: Treatmentmentioning

confidence: 99%

Surgical Treatment of Wounds Using Stem Cells in Epidermolysis Bullosa (EB)

Nita¹,

Pliszczyński²,

Eljaszewicz³

et al. 2021

Rare Diseases - Diagnostic and Therapeutic Odyssey

View full text Add to dashboard Cite

Epidermolysis bullosa (EB) is a group of hereditary skin diseases, or genodermatoses, characterized by the formation of severe, chronic blisters with painful and life-threatening complications. Despite the previous and ongoing progress in the field, there are still no effective causative treatments for EB. The treatment is limited to relieving symptoms, which—depending on disease severity—may involve skin (blisters, poorly healing wounds caused by the slightest mechanical stimuli, contractures, scarring, pseudosyndactyly) and internal organ abnormalities (esophageal, pyloric, or duodenal atresia; renal failure; and hematopoietic abnormalities). The last decade saw a series of important discoveries that paved the way for new treatment methods, including gene therapy, bone marrow transplantation, cell therapy (allogenic fibroblasts, mesenchymal stem cells [MSCs], and clinical use of induced pluripotent stem cells. Tissue engineering experts are attempting to develop skin-like structures that can facilitate the process of healing to promote skin reconstruction in injuries that are currently incurable. However, this is incredibly challenging, due to the complex structure and the many functions of the skin. Below, we characterize EB and present its potential treatment methods. Despite the cure for EB being still out of reach, recent data from animal models and initial clinical trials in humans have raised patients’, clinicians’, and researchers’ expectations. Consequently, modifying the course of the disease and improving the quality of life have become possible. Moreover, the conclusions drawn based on EB treatment may considerably improve the treatment of other genetic diseases.

show abstract

Randomized Clinical Trial of the Innovative Bilayered Wound Dressing Made of Silk and Gelatin: Safety and Efficacy Tests Using a Split-Thickness Skin Graft Model

Cited by 31 publications

References 22 publications

Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing

Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing

Meta-analysis and Systematic Review of Skin Graft Donor-site Dressings with Future Guidelines

Surgical Treatment of Wounds Using Stem Cells in Epidermolysis Bullosa (EB)

Contact Info

Product

Resources

About